Skip to main content

Table 5 Liver metabolism

From: First experience with Tolvaptan for the treatment of neonates and infants with capillary leak syndrome after cardiac surgery

Group

Parameter

Before TLV

Under TLV

After TLV

P-value

Responder (n = 17)

GGT (< 23 U/l)

41.5 (19–93)n = 8

95.5 (29–215) n = 6

118 (38–354) n = 9

0.2926

Non-responder (n = 8)

53.5 (17–220)

93 (34–352) n = 7

116.5 (24–845) n = 6

0.2223

Responder (n = 17)

AST (< 50 U/l)

22.5 (10–48) n = 8

20.5 (10–57) n = 8

23.5 (14–143) n = 10

0.4576

Non-responder (n = 8)

32.5 (11–638)

57 (14–252) n = 6

28.5 (13–50)

0.1677

Responder (n = 17)

ALT (< 26 U/l)

16 (9–30) n = 7

14 (6–178) n = 9

17.5 (10–26) n = 8

0.4987

Non-responder (n = 8)

30.5 (11–382)

51 (7–399) n = 7

21.5 (6–107)

0.1303

  1. Normal values for GGT, AST and ALT are expressed. Values are expressed as median and range. p < 0.05 has been considered as statistically significant